CompanyDeals

Takeda Partners with Biological E to Boost Production of Dengue Vaccine QDenga

CompanyDrug

FDA Withdraws Approval for Multiple Myeloma Drug Pepaxto Over Safety and Efficacy Concerns

CompanyDrug

Chia Tai Tianqing’s Anlotinib-Benmelstobart Combo Therapy Receives CDE Review for Endometrial Cancer

CompanyDrug

CanSino Biologics’ 13-Valent Pneumococcal Vaccine CRM197 Accepted for NMPA Review

CompanyMedical Device

Jenscare Scientific Achieves Milestone with First LuX-Valve Plus Implantation in Brazil

CompanyDeals

Viatris Secures Late-Stage Programs from Idorsia with Potential for Future Asset Additions

CompanyMedical Device

MicroPort CardioFlow Forecasts 31%-36% YOY Sales Growth for 2023 Driven by TAVI Product Expansion

Company

HutchMed’s 2023 Financials Show 102% YOY Revenue Growth and Robust Collaboration with Takeda

CompanyDeals

Angitia Bio Secures USD 40 Million in Series B+ Financing to Advance Musculoskeletal Disorder Therapies

CompanyDeals

BMS Taps into Circular RNA Potential with Shanghai Circode Bio Agreement

CompanyDeals

AbbVie Partners with OSE Immunotherapeutics to Develop First-in-Class Immunotherapy OSE-230

CompanyDrug

AstraZeneca’s AZD0486 Receives NMPA Greenlight for Clinical Study in B-Cell Leukemia